Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Capital Employed (2016 - 2026)

OptimizeRx's Return on Capital Employed history spans 15 years, with the latest figure at 7.68% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 1684.0% to 7.68% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.68%, a 1684.0% increase, with the full-year FY2025 number at 7.65%, up 1629.0% from a year prior.
  • Return on Capital Employed hit 7.68% in Q4 2025 for OptimizeRx, up from 4.47% in the prior quarter.
  • Over the last five years, Return on Capital Employed for OPRX hit a ceiling of 7.68% in Q4 2025 and a floor of 19.42% in Q4 2023.
  • Historically, Return on Capital Employed has averaged 6.89% across 5 years, with a median of 7.56% in 2022.
  • Biggest five-year swings in Return on Capital Employed: tumbled -1034bps in 2023 and later surged 2274bps in 2025.
  • Tracing OPRX's Return on Capital Employed over 5 years: stood at 0.28% in 2021, then tumbled by -3546bps to 9.69% in 2022, then crashed by -100bps to 19.42% in 2023, then surged by 53bps to 9.17% in 2024, then skyrocketed by 184bps to 7.68% in 2025.
  • Business Quant data shows Return on Capital Employed for OPRX at 7.68% in Q4 2025, 4.47% in Q3 2025, and 2.61% in Q2 2025.